Cargando…
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
INTRODUCTION: Mixed cryoglobulinemia (MC) is a HCV-related lymphoproliferative disorder generally associated with advanced liver disease. Liver stiffness has been significantly correlated with histopathological stage of fibrosis. Moreover, it was influenced by necroinflammatory activity. Rituximab (...
Autores principales: | Stasi, Cristina, Triboli, Elisa, Arena, Umberto, Urraro, Teresa, Petrarca, Antonio, Gragnani, Laura, Laffi, Giacomo, Zignego, Anna Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906886/ https://www.ncbi.nlm.nih.gov/pubmed/24456582 http://dx.doi.org/10.1186/1479-5876-12-21 |
Ejemplares similares
-
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia
por: Fognani, Elisa, et al.
Publicado: (2013) -
Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
por: Urraro, Teresa, et al.
Publicado: (2015) -
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
por: Quartuccio, Luca, et al.
Publicado: (2022) -
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
por: Quartuccio, Luca, et al.
Publicado: (2022) -
Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia
por: Genest, Dominique S., et al.
Publicado: (2021)